ASH 2023 | EMN26 clinical trial
Myeloma Patients Europe Myeloma Patients Europe
1K subscribers
127 views
0

 Published On Dec 15, 2023

Prof. Pieter Sonneveld, Professor of Haematology and Head of the Department of Haematology at the Erasmus MC Cancer Institute and Professor of Haematology at the Erasmus University of Rotterdam, The Netherlands, explains the main results of the EMN26 Study: iberdomide maintenance after autologous stem-cell tTransplantation.

show more

Share/Embed